Deucravacitinib in Moderate-to-Severe Plaque Psoriasis: A Real-World Study of Effectiveness and Safety in Clinical Practice

Key Points

• This study aims to evaluate the effectiveness and safety of deucravacitinib in treating moderate-to-severe plaque psoriasis in clinical practice.
• Real-world study design assessing treatment outcomes.
• Evaluation of effectiveness and safety profile in clinical settings.
• Data collected from routine clinical practice.
• Deucravacitinib demonstrated significant effectiveness in reducing psoriasis symptoms.
• Sustained treatment effects were observed over the study period.
• The safety profile was favorable, indicating it is a viable treatment option.